Loading stock data…
$22.55+0.14 (+0.60%)
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Elanco Animal Health Incorporated in the Healthcare sector is trading at $22.55 with a market capitalization of $11.5B. Wall Street consensus targets $31.00 (13 analysts), implying a +37.5% move over the next 12 months. The stock is currently 19% below its 52-week high of $27.98, remaining 5.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.37B↓ | $1.37B↑ | $1.14B↑ | $1.14B↓ | $1.24B |
| Gross Profit | $798.00M↑ | $785.00M↑ | $589.00M↓ | $607.00M↓ | $713.00M |
| Operating Income | $118.00M↓ | $169.00M↑ | $19.00M↓ | $27.00M↓ | $85.00M |
| Net Income | $54.00M↓ | $57.00M↑ | -$276.00M↓ | -$34.00M↓ | $11.00M |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that p...